Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein
about
Enhancement of CIITA transcriptional function by ubiquitinThe histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivatorHistone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formationZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcriptionCIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivationClass II transactivator: mastering the art of major histocompatibility complex expressionGenetics and visceral leishmaniasis: of mice and manMitogen-activated protein kinase ERK1/2 regulates the class II transactivatorSpecific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5Structural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHInterferon gamma repression of collagen (COL1A2) transcription is mediated by the RFX5 complexThe RFX family interacts at the collagen (COL1A2) start site and represses transcriptionRegulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor betaTwo distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domainsPromoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activationDysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.Novel functions for TAF7, a regulator of TAF1-independent transcription.CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complexNucleosome eviction from MHC class II promoters controls positioning of the transcription start site.CIITA and Its Dual Roles in MHC Gene Transcription.Recognition of bacterial infection by innate immune sensors.Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.Self-association of class II transactivator correlates with its intracellular localization and transactivation.The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic linesInvolvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator.Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.CIITA mediates interferon-gamma repression of collagen transcription through phosphorylation-dependent interactions with co-repressor molecules.Sequential modifications in class II transactivator isoform 1 induced by lipopolysaccharide stimulate major histocompatibility complex class II transcription in macrophages.Defective class II transactivator expression in a B lymphoma cell line.Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.Transcription factor effector domains.
P2860
Q22330796-CE78BBB5-3AAC-4014-8E62-3D8A5D0EA6FFQ22330805-78BA40E9-E2F8-471A-9B4B-446FBA9505F7Q24289051-18FB1FF3-3376-4452-89FB-3D296687B8DFQ24289418-55D2AEF7-5C33-4BF1-B657-7FF3E60FB13EQ24551176-A1945D51-7A8C-455E-BD4A-289D43C6052CQ24552298-185FD17C-CFBD-4B13-BC09-EB07EFA6FA55Q24612701-9802FECD-DED6-4CB4-9AC7-C8021BD59D1DQ24652921-75E11F11-6A7A-4C4A-9FE1-8B39FBFD562DQ24683275-BAFED483-4620-403C-BD49-9D8AB71BF007Q27682610-54D12B2F-5F95-444D-8039-E8AC64AB6D3FQ28206220-6AAC04D9-11C1-40F0-9F7A-03A599A266B0Q28216325-263D2980-B702-4352-8010-8EA3F49F177AQ30350982-72473C79-114C-4D66-9C7E-C97AA6A7DBC5Q33284534-2CC76DC6-219B-4283-8A9E-9AF47B5342B6Q33605603-823FC82A-4695-4190-B348-651089210652Q33944148-E47D6E2D-E9BB-49B8-A688-1D317D277864Q33957154-18B5FA8B-3CD4-4335-8C79-68832F5BC767Q33967979-87BA16D3-AAD7-4956-ADD0-7351E612BCCBQ34086182-89448181-361C-4132-AC0B-652BC29FC6F0Q34259906-447AD4E8-7EA6-4B71-A7CD-C23A0D4F24EBQ34385864-67E4A17E-5D0F-46E9-9527-D3EF65D45F6DQ35192842-FA4C55F0-D1FA-46BA-A445-B1D2AEDD6443Q37181516-67553441-BFC2-493C-A967-32A2B4882514Q37405448-7ECEE984-310D-4977-BA07-791146C9A9B4Q38032312-685D4988-99D1-46BA-9F37-0A0B257406E3Q38298691-85A0ADAD-D662-44FB-96DA-C69A1C2A40DEQ38299750-93806901-E5B3-4B11-A7DA-8BEB8E037E17Q38333945-6D4C0677-0768-467F-B297-6EEF28D0F4EFQ39318369-2D8E9BB4-77EC-4806-862F-BE04CE7D5740Q39459892-8A2785AC-6EB2-48DA-A462-F78056766C79Q39576629-07BE24C2-0F5B-4F4E-944E-CE136F419020Q39674999-20E74551-3AF3-4125-9CE8-C73A358725B2Q39695544-CF3E390F-6E54-463C-8952-C6EEF3F98321Q39927810-6291BC65-DB18-4DFB-B56A-44A4AAD36A0AQ40054485-F2A235EA-FBCB-422F-B50F-389CAB65873CQ40210146-197E5673-5706-4064-845D-653C64CCDF5EQ40587933-4189A8EC-2E68-4F5F-95E7-5D6ACBE6B479Q40699713-43E47A14-A3AC-44E2-8F97-EE23A880D166Q40735560-0C9FFFD0-8484-4FBF-A834-A02C4480AD5BQ42155239-7D31F3FA-41BE-4A37-AABD-149139B512AE
P2860
Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Transactivation by CIITA, the ...... f the TATA box binding protein
@ast
Transactivation by CIITA, the ...... f the TATA box binding protein
@en
Transactivation by CIITA, the ...... f the TATA box binding protein
@nl
type
label
Transactivation by CIITA, the ...... f the TATA box binding protein
@ast
Transactivation by CIITA, the ...... f the TATA box binding protein
@en
Transactivation by CIITA, the ...... f the TATA box binding protein
@nl
prefLabel
Transactivation by CIITA, the ...... f the TATA box binding protein
@ast
Transactivation by CIITA, the ...... f the TATA box binding protein
@en
Transactivation by CIITA, the ...... f the TATA box binding protein
@nl
P2093
P2860
P356
P1476
Transactivation by CIITA, the ...... f the TATA box binding protein
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.12.6324
P407
P577
1997-06-10T00:00:00Z